These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 26040603)

  • 21. Applications and advances of CRISPR/Cas9 in animal cancer model.
    Xu M; Weng Q; Ji J
    Brief Funct Genomics; 2020 May; 19(3):235-241. PubMed ID: 32124927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Cas system: a powerful tool for genome engineering.
    Liu L; Fan XD
    Plant Mol Biol; 2014 Jun; 85(3):209-18. PubMed ID: 24639266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals.
    Mojica FJM; Montoliu L
    Trends Microbiol; 2016 Oct; 24(10):811-820. PubMed ID: 27401123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA fragment editing of genomes by CRISPR/Cas9.
    Li JH; Shou J; Wu Q
    Yi Chuan; 2015 Oct; 37(10):992-1002. PubMed ID: 26496751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.
    Smith C; Gore A; Yan W; Abalde-Atristain L; Li Z; He C; Wang Y; Brodsky RA; Zhang K; Cheng L; Ye Z
    Cell Stem Cell; 2014 Jul; 15(1):12-3. PubMed ID: 24996165
    [No Abstract]   [Full Text] [Related]  

  • 29. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Genetic Basis of Reporter Mouse Strains.
    Kim GN; Sung YH
    Adv Exp Med Biol; 2021; 1310():551-564. PubMed ID: 33834450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular organization of the type II-A CRISPR adaptation module and its interaction with Cas9 via Csn2.
    Ka D; Jang DM; Han BW; Bae E
    Nucleic Acids Res; 2018 Oct; 46(18):9805-9815. PubMed ID: 30102386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome editing using Cas9 nickases.
    Trevino AE; Zhang F
    Methods Enzymol; 2014; 546():161-74. PubMed ID: 25398340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified and efficient germline-specific CRISPR/Cas9 system for Drosophila genomic engineering.
    Sebo ZL; Lee HB; Peng Y; Guo Y
    Fly (Austin); 2014; 8(1):52-7. PubMed ID: 24141137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of CRISPR/Cas9 technology in sepsis research.
    Wu M; Hu N; Du X; Wei J
    Brief Funct Genomics; 2020 May; 19(3):229-234. PubMed ID: 32058568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.